⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CTMX News
CytomX Therapeutics, Inc.
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
globenewswire.com
CTMX
CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
CTMX
CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
globenewswire.com
CTMX
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
globenewswire.com
CTMX